BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 9430237)

  • 1. Effects of nitric oxide synthase inhibitors on bone formation in rats.
    Turner CH; Owan I; Jacob DS; McClintock R; Peacock M
    Bone; 1997 Dec; 21(6):487-90. PubMed ID: 9430237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of endothelial nitric oxide synthase in estrogen-induced osteogenesis.
    Samuels A; Perry MJ; Gibson RL; Colley S; Tobias JH
    Bone; 2001 Jul; 29(1):24-9. PubMed ID: 11472887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of endothelial and inducible nitric oxide synthases inhibition on circulatory function in rats after myocardial infarction.
    Gaballa MA; Raya TE; Hoover CA; Goldman S
    Cardiovasc Res; 1999 Jun; 42(3):627-35. PubMed ID: 10533602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic administration of aminoguanidine reduces vascular nitric oxide production and attenuates liver damage in bile duct-ligated rats.
    Wei CL; Hon WM; Lee KH; Khoo HE
    Liver Int; 2005 Jun; 25(3):647-56. PubMed ID: 15910502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An endothelial nitric oxide synthase inhibitor aggravates CDL-induced acute pancreatitis in rats.
    Nishino T; Watanabe S; Oyama H; Fukuya Y; Hayashi N; Kobayashi M
    Pancreas; 1999 Nov; 19(4):390-400. PubMed ID: 10547200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experiments with nitric oxide synthase inhibitors in spinal nerve ligated rats provide no evidence of a role for nitric oxide in neuropathic mechanical allodynia.
    Lee DH; Singh JP; Lodge D
    Neurosci Lett; 2005 Sep; 385(3):179-83. PubMed ID: 15964141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide-inhibitory effect of aminoguanidine on renal function in rats.
    Waz WR; Van Liew JB; Feld LG
    Kidney Blood Press Res; 1997; 20(4):211-7. PubMed ID: 9398025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of nNOS in blood pressure regulation in eNOS null mutant mice.
    Kurihara N; Alfie ME; Sigmon DH; Rhaleb NE; Shesely EG; Carretero OA
    Hypertension; 1998 Nov; 32(5):856-61. PubMed ID: 9822444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual role for nitric oxide in dynorphin spinal neurotoxicity.
    Hu WH; Li F; Qiang WA; Liu N; Wang GQ; Xiao J; Liu JS; Liao WH; Jen MF
    J Neurotrauma; 1999 Jan; 16(1):85-98. PubMed ID: 9989468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible nitric oxide synthase and blood pressure.
    Mattson DL; Maeda CY; Bachman TD; Cowley AW
    Hypertension; 1998 Jan; 31(1):15-20. PubMed ID: 9449384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform.
    Southan GJ; Zingarelli B; O'Connor M; Salzman AL; Szabó C
    Br J Pharmacol; 1996 Feb; 117(4):619-32. PubMed ID: 8646406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of inducible nitric oxide in ischemia-reperfusion of rat small intestine.
    Chen JC; Chen HM; Shyr MH; Fan LL; Chi TY; Chi CP; Chen MF
    J Formos Med Assoc; 2000 Mar; 99(3):213-8. PubMed ID: 10820953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide in skeletal muscle: inhibition of nitric oxide synthase inhibits walking speed in rats.
    Wang MX; Murrell DF; Szabo C; Warren RF; Sarris M; Murrell GA
    Nitric Oxide; 2001 Jun; 5(3):219-32. PubMed ID: 11384195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible nitric oxide synthase inhibitors abolished histological protection by late ischemic preconditioning in rat retina.
    Sakamoto K; Yonoki Y; Kubota Y; Kuwagata M; Saito M; Nakahara T; Ishii K
    Exp Eye Res; 2006 Mar; 82(3):512-8. PubMed ID: 16198335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of responses to aminoguanidine and N omega-nitro-L-arginine methyl ester in the rat aorta.
    Yen MH; Chen SJ; Wu CC
    Clin Exp Pharmacol Physiol; 1995 Sep; 22(9):641-5. PubMed ID: 8542678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-dependent aggravation or attenuation of lipopolysaccharide-induced gastric injury by nitric oxide synthase inhibition.
    Suliburk JW; Helmer KS; Kennison SD; Mercer DW; Robinson EK
    J Surg Res; 2005 Dec; 129(2):265-71. PubMed ID: 16026802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective iNOS inhibition prevents hypotension in septic rats while preserving endothelium-dependent vasodilation.
    Strunk V; Hahnenkamp K; Schneuing M; Fischer LG; Rich GF
    Anesth Analg; 2001 Mar; 92(3):681-7. PubMed ID: 11226101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide synthase inhibition negates bombesin-induced gastroprotection.
    Castañeda AA; Kim YS; Chang LK; Cui Y; Mercer DW
    Surgery; 2000 Sep; 128(3):422-8. PubMed ID: 10965314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of chronic nitric oxide synthesis inhibition on blood pressure and angiotensin II responsiveness in the pregnant rat.
    Lubarsky SL; Ahokas RA; Friedman SA; Sibai BM
    Am J Obstet Gynecol; 1997 May; 176(5):1069-76. PubMed ID: 9166170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of nitric oxide synthase inhibitors in an in vivo allergic rat model.
    Tulić MK; Wale JL; Holt PG; Sly PD
    Eur Respir J; 2000 May; 15(5):870-7. PubMed ID: 10853851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.